Nuvama Initiates Aequs at Buy, ₹444 Target Implies ~92% Upside on Aerospace Growth Play

Broker sees Aequs as a China+1 and Make-in-India beneficiary supplying Airbus/Boeing ecosystem; aggressive target warrants scrutiny given illiquidity, single-broker view, and absent EBITDA detail.

ndtv-profit-business · 7/7/2026, 3:32:27 AM · Ask about this →